Personensuche
Personensuche
Es wurde 1 Person gefunden.
Institut für Pathologie am Universitätsklinikum Essen
E-Mail
Funktionen
-
Universitätsprofessor/in, Institut für Pathologie
Aktuelle Veranstaltungen
Keine aktuellen Veranstaltungen.
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
-
WiSe 2023
-
SoSe 2022
-
WiSe 2021
-
SoSe 2021
-
WiSe 2020
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Beyond driver mutations : Exploring the landscape of mutational signatures in adenocarcinomas of the bladderIn: The Journal of Pathology, Jg. 263, 2024, Nr. 4-5, S. 400 – 402DOI (Open Access)
-
Clinical sequencing identifies potential actionable alterations in a high rate of urachal and primary bladder adenocarcinomasIn: Cancer Medicine, Jg. 12, 2023, Nr. 7, S. 9041 – 9054DOI (Open Access)
-
Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy : A Prospective Randomized TrialIn: European Urology Oncology, Jg. 6, 2023, Nr. 1, S. 49 – 55
-
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer : Results of a Binational SurveyIn: Urologia Internationalis, Jg. 107, 2023, Nr. 1, S. 35 – 45DOI, Online Volltext (Open Access)
-
Identification of a new prognostic score for patients with high-grade metastatic GEP-NEN treated with palliative chemotherapyIn: Journal of Cancer Research and Clinical Oncology, Jg. 149, 2023, Nr. 8, S. 4315 – 4325DOI (Open Access)
-
Immune-Checkpoint-Inhibitor Therapy : Principles and Relevance of Biomarkers for Pathologists and OncologistsIn: Advances in Anatomic Pathology, Jg. 30, 2023, Nr. 3, S. 160 – 166
-
Intraoperative Molecular Positron Emission Tomography Imaging for Intraoperative Assessment of Radical Prostatectomy SpecimensIn: European Urology Open Science, Jg. 54, 2023, S. 28 – 32DOI (Open Access)
-
Optimizing identification of consensus molecular subtypes in muscle-invasive bladder cancer : a comparison of two sequencing methods and gene sets using FFPE specimensIn: BMC Cancer, Jg. 23, 2023, Nr. 1, 504DOI (Open Access)
-
Predictive value of molecular subtypes and APOBEC3G for adjuvant chemotherapy in urothelial bladder cancerIn: Cancer Medicine, Jg. 12, 2023, Nr. 5, S. 5222 – 5232DOI, Online Volltext (Open Access)
-
A quantitative polymerase chain reaction based method for molecular subtype classification of urinary bladder cancer : Stromal gene expressions show higher prognostic values than intrinsic tumor genesIn: International Journal of Cancer, Jg. 150, 2022, Nr. 5, S. 856 – 867DOI (Open Access)
-
Clinical outcome and quality of life in octogenarian patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy or transurethral resection of the bladder tumor : a retrospective analysis of 143 patientsIn: International Urology and Nephrology, Jg. 54, 2022, Nr. 1, S. 71 – 79DOI (Open Access)
-
Commentary: Treatment Outcome of Different Chemotherapy in Patients With Relapsed or Metastatic Malignant Urachal TumorIn: Frontiers in Oncology, Jg. 12, 2022, 864708DOI (Open Access)
-
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapyIn: BMC Cancer, Jg. 22, 2022, Nr. 1, 46DOI, Online Volltext (Open Access)
-
Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for SurvivalIn: Cancers, Jg. 14, 2022, Nr. 19, 4867DOI (Open Access)
-
Proteasomal Processing Immune Escape Mechanisms in Platinum-Treated Advanced Bladder CancerIn: Genes, Jg. 13, 2022, Nr. 3, 422DOI (Open Access)
-
Rebiopsy in advanced non-small cell lung cancer, clinical relevance and prognostic implicationsIn: Lung Cancer, Jg. 168, 2022, S. 10 – 20
-
Retrograde Pyelography in the Presence of Urothelial Bladder Cancer Does Not Affect the Risk of Upper Tract Urothelial Cancer : A Retrospective Analysis of a Single-Centre CohortIn: Urologia Internationalis, Jg. 106, 2022, S. 638 – 643
-
Strukturierte Befundung am Beispiel des Prostatakarzinoms : Selbstentwicklung einer digitalen Lösung für ProstatastanzbiopsienIn: Die Pathologie, Jg. 43, 2022, Nr. Suppl. 1, S. 94 – 100
-
The Prognostic Value of Cytokeratin and Extracellular Collagen Expression in Urinary Bladder CancerIn: Current Molecular Medicine, Jg. 22, 2022, Nr. 10, S. 941 – 949
-
Three-dimensional Magnetic Resonance Imaging-based Printed Models of Prostate Anatomy and Targeted Biopsy-proven Index Tumor to Facilitate Patient-tailored Radical Prostatectomy : A Feasibility StudyIn: European Urology Oncology, Jg. 5, 2022, Nr. 3, S. 357 – 361DOI, Online Volltext (Open Access)
-
Treatment outcome of atypical EGFR mutations in the German National Network Genomic Medicine Lung Cancer (nNGM)In: Annals of Oncology, Jg. 33, 2022, Nr. 6, S. 602 – 615DOI (Open Access)
-
A new technological approach in diagnostic pathology : Mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancerIn: Laboratory Investigation, Jg. 101, 2021, Nr. 9, S. 1281 – 1288DOI (Open Access)
-
Antitumor immune response is associated with favorable survival in GEP-NEN G3In: Endocrine-Related Cancer, Jg. 28, 2021, Nr. 10, S. 683 – 693
-
Apoptotic Gastritis in Melanoma Patients Treated With PD-1-Based Immune Checkpoint Inhibition : Clinical and Histopathological Findings Including the Diagnostic Value of Anti-Caspase-3 ImmunohistochemistryIn: Frontiers in Oncology, Jg. 11, 2021, 725549DOI, Online Volltext (Open Access)
-
BRAF mutations and BRAF mutation functional class have no negative impact on the clinical outcome of advanced NSCLC and associate with susceptibility to immunotherapyIn: European Journal of Cancer (EJC), Jg. 149, 2021, S. 211 – 221
-
Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up : A monocentre studyIn: European Journal of Cancer (EJC), Jg. 154, 2021, S. 167 – 174
-
Correction to: : A new technological approach in diagnostic pathology: mass spectrometry imaging-based metabolomics for biomarker detection in urachal cancerIn: Laboratory Investigation, Jg. 101, 2021, Nr. 10, S. 1414DOI (Open Access)
-
Detection of Significant Prostate Cancer Using Target Saturation in Transperineal Magnetic Resonance Imaging/Transrectal Ultrasonography–fusion BiopsyIn: European Urology Focus, Jg. 7, 2021, Nr. 6, S. 1300 – 1307DOI, Online Volltext (Open Access)
-
Enzalutamide enhances psma expression of psma-low prostate cancerIn: International Journal of Molecular Sciences (IJMS), Jg. 22, 2021, Nr. 14, 7431DOI, Online Volltext (Open Access)
-
High serum pd-l1 levels are associated with poor survival in urothelial cancer patients treated with chemotherapy and immune checkpoint inhibitor therapyIn: Cancers, Jg. 13, 2021, Nr. 11, 2548DOI, Online Volltext (Open Access)
-
Increased expression of akt3 in neuroendocrine differentiated prostate cancer cells alters the response towards anti‐androgen treatmentIn: Cancers, Jg. 13, 2021, Nr. 3, S. 578DOI, Online Volltext (Open Access)
-
MMP-7 Serum and Tissue Levels Are Associated with Poor Survival in Platinum-Treated Bladder Cancer PatientsIn: Diagnostics, Jg. 11, 2021, Nr. 1, 48DOI, Online Volltext (Open Access)
-
Molecular characterization of muellerian tumors of the urinary tractIn: Genes, Jg. 12, 2021, Nr. 6, 880DOI (Open Access)
-
Multiple Hepatic and Pulmonary Tumors Combined with Bilateral Adrenal Masses in a Young Woman with von Hippel–Lindau DiseaseIn: Gastroenterology, Jg. 161, 2021, Nr. 4, S. e1 – e4DOI (Open Access)
-
Nodulärer Tumor eines Ductus deferens mit epithelialen VerbändenIn: Der Pathologe, Jg. 42, 2021, Nr. 6, S. 598 – 601
-
Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging : Utilization of a short-pass filter to reduce technical pitfallsIn: Translational Andrology and Urology, Jg. 10, 2021, Nr. 10, S. 3972 – 3985DOI (Open Access)
-
Sitzungsbericht der Arbeitsgemeinschaft Uropathologie der Deutschen Gesellschaft für Pathologie 2021In: Der Pathologe, Jg. 42, 2021, S. 203 – 204DOI (Open Access)
-
The Biomarker Potential of Caveolin-1 in Penile CancerIn: Frontiers in Oncology, Jg. 11, 2021, S. 606122DOI, Online Volltext (Open Access)
-
The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of NeoplasiaIn: Advances in Anatomic Pathology, Jg. 28, 2021, Nr. 4, S. 179 – 195
-
The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial CancersIn: Advances in Anatomic Pathology, Jg. 28, 2021, Nr. 4, S. 196 – 208
-
The detection of isochromosome i(12p) in malignant germ cell tumours and tumours with somatic malignant transformation by the use of quantitative real-time polymerase chain reactionIn: Histopathology, Jg. 78, 2021, Nr. 4, S. 593 – 606DOI (Open Access)
-
Zystisches Nephrom bei einem 15 Monate alten Patienten mit DICER1-MutationIn: Der Urologe, Jg. 60, 2021, Nr. 6, S. 776 – 779
-
Angiomyolipom der Leber : Ein Fallbericht in Zusammenschau mit der LiteraturIn: Der Pathologe, Jg. 41, 2020, Nr. 6, S. 643 – 648
-
Biweekly Cetuximab Plus FOLFOX6 as First-Line Therapy in Patients With RAS Wild-Type Metastatic Colorectal Cancer : The CEBIFOX TrialIn: Clinical Colorectal Cancer, Jg. 19, 2020, Nr. 4, S. 236 – 247.e6
-
Caveolin-1 regulates the ASMase/ceramide-mediated radiation response of endothelial cells in the context of tumor–stroma interactionsIn: Cell Death and Disease, Jg. 11, 2020, Nr. 4, 228DOI (Open Access)
-
Clinical response to crizotinib and emergence of resistance in lung adenocarcinoma harboring a MET c-Cbl binding site mutationIn: Lung Cancer, Jg. 139, 2020, S. 165 – 168
-
Comparative genomic profiling of glandular bladder tumoursIn: Virchows Archiv, 2020DOI (Open Access)
-
ERK phosphorylation as a marker of RAS activity and its prognostic value in non-small cell lung cancerIn: Lung Cancer, Jg. 149, 2020, S. 10 – 16
-
Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor : A hospital-based cancer registry data in JapanIn: International Journal of Urology, Jg. 27, 2020, Nr. 2, S. 163 – 164
-
Ektopes Schilddrüsengewebe in der Nebenniere : Ein Fallbericht in Zusammenschau mit der LiteraturIn: Der Pathologe, Jg. 41, 2020, Nr. 2, S. 177 – 180
-
First-in-man intraoperative Cerenkov luminescence imaging for oligometastatic prostate cancer using ⁶⁸Ga-PSMA-11In: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 47, 2020, Nr. 13, S. 3194 – 3195
-
GNAQ and GNA11 mutant nonuveal melanoma : A subtype distinct from both cutaneous and uveal melanomaIn: British Journal of Dermatology: BJD, Jg. 183, 2020, Nr. 5, S. 928 – 939DOI (Open Access)
-
Intraoperative 68Gallium-PSMA Cerenkov Luminescence Imaging for surgical margins in radical prostatectomy : A feasibility studyIn: Journal of Nuclear Medicine (JNM), Jg. 61, 2020, Nr. 10, S. 1500 – 1506DOI, Online Volltext (Open Access)
-
Machine learning reveals a PD-L1–independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression contextIn: European Journal of Cancer (EJC), Jg. 140, 2020, S. 76 – 85
-
Nuclear Localization of Robo is Associated with Better Survival in Bladder CancerIn: Pathology & Oncology Research, Jg. 26, 2020, Nr. 1, S. 253 – 261
-
Plasma next generation sequencing and droplet digital-qpcr-based quantification of circulating cell-free rna for noninvasive early detection of cancerIn: Cancers, Jg. 12, 2020, Nr. 2, 353DOI, Online Volltext (Open Access)
-
Prevalence of APC and PTEN Alterations in Urachal CancerIn: Pathology & Oncology Research, Jg. 26, 2020, Nr. 4, S. 2773 – 2781DOI (Open Access)
-
STIP1 Tissue Expression Is Associated with Survival in Chemotherapy-Treated Bladder Cancer PatientsIn: Pathology & Oncology Research, Jg. 26, 2020, Nr. 2, S. 1243 – 1249
-
Serum and tissue syndecan-1 levels in renal cell carcinomaIn: Translational Andrology and Urology, Jg. 9, 2020, Nr. 3, S. 1167 – 1176DOI (Open Access)
-
Soluble syndecan-1 levels are associated with survival in platinum-treated bladder cancer patientsIn: Diagnostics, Jg. 10, 2020, Nr. 11, 864DOI, Online Volltext (Open Access)
-
Status der Verfügbarkeit und Anwendung von „next generation sequencing“ (NGS) beim Harnblasenkarzinom – eine Umfrage in der Arbeitsgemeinschaft UropathologieIn: Der Urologe, Jg. 59, 2020, Nr. 3, S. 318 – 325
-
Urachal cancer in Germany and the USA : An RKI/SEER population-based comparison studyIn: Urologia Internationalis, Jg. 104, 2020, Nr. 9-10, S. 803 – 809
-
Circulating and tissue IMP3 levels are correlated with poor survival in renal cell carcinomaIn: International Journal of Cancer, Jg. 145, 2019, Nr. 2, S. 531 – 539
-
Classic bladder exstrophy and adenocarcinoma of the bladder : Methylome analysis provide no evidence for underlying disease-mechanisms of this associationIn: Cancer Genetics, Jg. 235-236, 2019, S. 18 – 20
-
Das Urachuskarzinom : Ein Update aktueller molekularer ErgebnisseIn: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 3, S. 239 – 243
-
High soluble CGA levels are associated with poor survival in bladder cancerIn: Endocrine Connections, Jg. 8, 2019, Nr. 5, S. 625 – 633DOI, Online Volltext (Open Access)
-
Impact of RAS mutation subtype on clinical outcome : A cross-entity comparison of patients with advanced non-small cell lung cancer and colorectal cancerIn: Oncogene, Jg. 38, 2019, Nr. 16, S. 2953 – 2966
-
Long-term Survival after resection for perihilar cholangiocarcinoma : Impact of UICC staging and surgical procedureIn: The Turkish Journal of Gastroenterology, Jg. 30, 2019, Nr. 5, S. 454 – 460DOI, Online Volltext (Open Access)
-
Machine learning-based predictors for immune checkpoint inhibitor therapy of non-small-cell lung cancerIn: Annals of Oncology, Jg. 30, 2019, Nr. 4, S. 655 – 657DOI (Open Access)
-
Neoadjuvant cisplatin-based chemotherapy in “primary” and “secondary” muscle-invasive bladder cancer—is it a surrogate for molecular subtypes?In: Translational Cancer Research, Jg. 8, 2019, Nr. Suppl. 2, S. 176 – S179DOI (Open Access)
-
PD-L1 Expression in Urothelial Carcinoma with Predominant or Pure Variant Histology : Concordance among 3 Commonly Used and Commercially Available AntibodiesIn: The American Journal of Surgical Pathology, Jg. 43, 2019, Nr. 7, S. 920 – 927DOI, Online Volltext (Open Access)
-
Programmed Death Ligand 1 (PD-L1) Status and Tumor-Infiltrating Lymphocytes in Hot Spots of Primary and Liver Metastases in Prostate Cancer With Neuroendocrine DifferentiationIn: Clinical Genitourinary Cancer, Jg. 17, 2019, Nr. 2, S. 145 – 153.e5
-
Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1In: Journal of Clinical Medicine (JCM), Jg. 8, 2019, Nr. 3, 348DOI, Online Volltext (Open Access)
-
Prospective comparison of ¹⁸F-FDG PET/MRI and ¹⁸F-FDG PET/CT for thoracic staging of non-small cell lung cancerIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 46, 2019, Nr. 2, S. 437 – 445
-
Prädiktive Biomarker in der onkologischen UropathologieIn: Der Pathologe, Jg. 40, 2019, Nr. 3, S. 264 – 275
-
TRIM58 Restrains Intestinal Mucosal Inflammation by Negatively Regulating TLR2 in Myeloid CellsIn: The Journal of Immunology (JI), Jg. 203, 2019, Nr. 6, S. 1636 – 1649DOI (Open Access)
-
Therapieprädiktive Biomarker des HarnblasenkarzinomsIn: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 3, S. 331 – 338
-
Urachal cancer : current concepts of a rare cancerIn: Der Pathologe, Jg. 40, 2019, Nr. Suppl. 1, S. 31 – 39
-
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations, Jg. 37, 2019, Nr. 11, S. 810.e7 – 810.e15
-
Biomarkers in Urachal Cancer and Adenocarcinomas in the Bladder : A Comprehensive Review Supplemented by Own DataIn: Disease Markers, 2018, 7308168DOI (Open Access)
-
CA19-9 beim intrahepatischen Cholangiokarzinom : Ein diagnostisches und prognostisches Armamentarium?In: Der Chirurg, Jg. 89, 2018, Nr. 6, S. 466 – 471
-
Circulating syndecan-1 is associated with chemotherapy-resistance in castration-resistant prostate cancerIn: Urologic Oncology: Seminars and Original Investigations, Jg. 36, 2018, Nr. 6, S. 312.e9 – 312.e15DOI, Online Volltext (Open Access)
-
Comparison of the sixth and the seventh editions of the UICC classification for intrahepatic cholangiocarcinomaIn: European Journal of Medical Research, Jg. 23, 2018, Nr. 1, S. 29DOI (Open Access)
-
Das Urachuskarzinom : aktuelle Konzepte einer seltenen TumorerkrankungIn: Der Pathologe, Jg. 39, 2018, Nr. Supplement 2, S. 291 – 300
-
MET Expression in Advanced Non–Small-Cell Lung Cancer : Effect on Clinical Outcomes of Chemotherapy, Targeted Therapy, and ImmunotherapyIn: Clinical Lung Cancer, Jg. 19, 2018, Nr. 4, S. e441 – e463
-
NF1 mutations in conjunctival melanomaIn: British Journal of Cancer (BJC), Jg. 118, 2018, Nr. 9, S. 1243 – 1247DOI (Open Access)
-
Pathogenic and targetable genetic alterations in 70 urachal adenocarcinomasIn: International Journal of Cancer, Jg. 143, 2018, Nr. 7, S. 1764 – 1773DOI, Online Volltext (Open Access)
-
Phosphorylation of p70 Ribosomal Protein S6 Kinase β-1 is an Independent Prognostic Parameter in Metastatic Colorectal CancerIn: Clinical Colorectal Cancer, Jg. 17, 2018, Nr. 2, S. e331 – e352
-
The Role of YKL-40 in Predicting Resistance to Docetaxel Chemotherapy in Prostate CancerIn: Urologia Internationalis, Jg. 101, 2018, Nr. 1, S. 65 – 73
-
Annexin A10 optimally differentiates between intrahepatic cholangiocarcinoma and hepatic metastases of pancreatic ductal adenocarcinoma : a comparative study of immunohistochemical markers and panelsIn: Virchows Archiv, Jg. 470, 2017, Nr. 5, S. 537 – 543
-
Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitisIn: European Journal of Cancer (EJC), Jg. 86, 2017, S. 248 – 256
-
Eukaryotic elongation factor 2 is a prognostic marker and its kinase a potential therapeutic target in HCC.In: OncoTarget, Jg. 8, 2017, Nr. 7, S. 11950 – 11962DOI (Open Access)
-
Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris MelanomaIn: Investigative Ophthalmology & Visual Science (IOVS), Jg. 58, 2017, Nr. 9, S. 3464 – 3470DOI (Open Access)
-
High Prevalence of Concomitant Oncogene Mutations in Prospectively Identified Patients with ROS1-Positive Metastatic Lung CancerIn: Journal of Thoracic Oncology, Jg. 12, 2017, Nr. 1, S. 54 – 64DOI (Open Access)
-
Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladderIn: Journal of Cancer Research and Clinical Oncology, Jg. 143, 2017, Nr. 9, S. 1659 – 1670
-
Liver steatosis in pre-transplant liver biopsies can be quantified rapidly and accurately by nuclear magnetic resonance analysisIn: Virchows Archiv, Jg. 470, 2017, Nr. 2, S. 197 – 204
-
MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesisIn: PLoS ONE, Jg. 12, 2017, Nr. 7, S. e0180834DOI (Open Access)
-
Markers of Hippo-Pathway Activity in Tumor Forming Liver LesionsIn: Pathology & Oncology Research, Jg. 23, 2017, Nr. 1, S. 33 – 39
-
Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapyIn: OncoTarget, Jg. 8, 2017, Nr. 28, S. 45898 – 45917DOI (Open Access)
-
Progression-related loss of stromal Caveolin 1 levels fosters the growth of human PC3 xenografts and mediates radiation resistanceIn: Scientific Reports, Jg. 7, 2017, S. 41138DOI, Online Volltext (Open Access)
-
Response to: Absence of GNAS and BRAF mutations but presence of KRAS mutation in urachal adenocarcinomaIn: Pathology, Jg. 49, 2017, Nr. 5, S. 561 – 562
-
SF3B1 and BAP1 mutations in blue nevus-like melanomaIn: Modern Pathology, Jg. 30, 2017, Nr. 7, S. 928 – 939DOI, Online Volltext (Open Access)
-
Serum Chromogranin A as a Complementary Marker for the Prediction of Prostate Cancer-Specific SurvivalIn: Pathology & Oncology Research, Jg. 23, 2017, Nr. 3, S. 643 – 650
-
Telomerase reverse transcriptase (TERT) promoter mutations are rare in urachal cancerIn: Pathology International, Jg. 67, 2017, Nr. 12, S. 597 – 601
-
The role of beta-catenin mutation and SOX9 expression in sex cord-stromal tumours of the testisIn: Virchows Archiv, Jg. 470, 2017, Nr. 4, S. 421 – 428
-
Characterization of pancreatic glucagon-producing tumors and pituitary gland tumors in transgenic mice overexpressing MYCN in hGFAP-positive cellsIn: OncoTarget, Jg. 7, 2016, Nr. 46, S. 74415 – 74426DOI (Open Access)
-
Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patientsIn: Journal of Cancer Research and Clinical Oncology, Jg. 142, 2016, Nr. 4, S. 795 – 805
-
Circulating and Tissue Expression Levels of YKL-40 in Renal Cell CancerIn: The Journal of Urology, Jg. 195, 2016, Nr. 4, S. 1120 – 1125
-
Clinical Sequencing-guided Therapy of Urachal Carcinoma : New Perspective for a Rare CancerIn: European Urology, Jg. 70, 2016, Nr. 5, S. 776 – 777
-
Clinical, prognostic, and therapeutic aspects of urachal carcinoma—A comprehensive review with meta-analysis of 1,010 casesIn: Urologic Oncology: Seminars and Original Investigations, Jg. 34, 2016, Nr. 9, S. 388 – 398
-
End-ischemic reconditioning of liver allografts : Controlling the rewarmingIn: Liver Transplantation, Jg. 22, 2016, Nr. 9, S. 1223 – 1230
-
MiR-205 and MiR-373 Are Associated with Aggressive Human Mucinous Colorectal CancerIn: PLoS ONE, Jg. 11, 2016, Nr. 6, S. e0156871DOI (Open Access)
-
Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma : Occurence and prognostic significanceIn: OncoTarget, Jg. 7, 2016, Nr. 26, S. 39293 – 39301DOI (Open Access)
-
Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesionsIn: Journal of Clinical Pathology: JCP Online, Jg. 69, 2016, Nr. 7, S. 619 – 626
-
Oncogene status as a diagnostic tool in ocular and cutaneous melanomaIn: European Journal of Cancer (EJC), Jg. 57, 2016, S. 112 – 117
-
Quantitative proteome analysis reveals the correlation between endocytosis-associated proteins and hepatocellular carcinoma dedifferentiationIn: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Jg. 1864, 2016, Nr. 11, S. 1579 – 1585
-
Soluble syndecan-1 (SDC1) serum level as an independent pre-operative predictor of cancer-specific survival in prostate cancerIn: The Prostate, Jg. 76, 2016, Nr. 11, S. 977 – 985
-
Urachal Carcinoma of the Bladder: Impact of Clinical and Immunohistochemical Parameters on PrognosisIn: The Journal of Urology, Jg. 195, 2016, Nr. 6, S. 1690 – 1695
-
Validation of the diagnostic and prognostic relevance of serum MMP-7 levels in renal cell cancer by using a novel automated fluorescent immunoassay methodIn: International Urology and Nephrology, Jg. 48, 2016, Nr. 3, S. 355 – 361
-
(Cleaved) CK18 serum and tissue expression levels differentiate acute HCV reinfection from acute rejection in liver allograftsIn: Liver International, Jg. 35, 2015, Nr. 3, S. 905 – 913
-
A structured proteomic approach identifies 14-3-3Sigma as a novel and reliable protein biomarker in panel based differential diagnostics of liver tumorsIn: Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Jg. 1854, 2015, Nr. 6, S. 641 – 650
-
Analysis of SDHD promoter mutations in various types of melanomaIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG), Jg. 13, 2015, Nr. Suppl. 2, S. 11
-
Analysis of SDHD promoter mutations in various types of melanomaIn: OncoTarget, Jg. 6, 2015, Nr. 28, S. 25868 – 25882DOI (Open Access)
-
Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in lymph node metastases of non-small cell lung cancer (NSCLC) patients using hybrid 18F-FDG PET/MRIIn: PLoS ONE, Jg. 10, 2015, Nr. 1, e0116277DOI (Open Access)
-
Endothelial Caveolin-1 regulates the radiation response of epithelial prostate tumorsIn: Oncogenesis, Jg. 4, 2015, S. e148DOI (Open Access)
-
Frequent TERT Promoter Mutations in Ocular Surface Squamous NeoplasiaIn: Investigative Ophthalmology & Visual Science (IOVS), Jg. 56, 2015, Nr. 10, S. 5854 – 5861DOI (Open Access)
-
HER2 expression and markers of phosphoinositide-3-kinase pathway activation define a favorable subgroup of metastatic pulmonary adenocarcinomasIn: Lung Cancer, Jg. 88, 2015, Nr. 1, S. 34 – 41
-
Thoracic staging of non-small-cell lung cancer using integrated ¹⁸F-FDG PET/MR imaging : diagnostic value of different MR sequencesIn: European Journal of Nuclear Medicine and Molecular Imaging, Jg. 42, 2015, Nr. 8, S. 1257 – 1267
-
Enhanced stromal syndecan-1 expression is an independent risk factor for poor survival in bladder cancerIn: Human Pathology, Jg. 45, 2014, Nr. 4, S. 674 – 682
-
Identification of novel biomarker candidates for the immunohistochemical diagnosis of cholangiocellular carcinomaIn: Molecular and Cellular Proteomics (MCP), Jg. 13, 2014, Nr. 10, S. 2661 – 2672
-
Prognostic effect of serum and tissue YKL-40 levels in bladder cancerIn: Urologic Oncology: Seminars and Original Investigations, Jg. 32, 2014, Nr. 5, S. 663 – 669
-
Prognostic value of tissue and circulating levels of IMP3 in prostate cancerIn: International Journal of Cancer, Jg. 135, 2014, Nr. 7, S. 1596 – 1604DOI (Open Access)
-
Re: Association of Oncofetal Protein Expression with Clinical Outcomes in Patients with Urothelial Carcinoma of the BladderIn: The Journal of Urology, Jg. 192, 2014, Nr. 2, S. 617 – 618
-
Thoracic staging in lung cancer : prospective comparison of 18F-FDG PET/MR imaging and 18F-FDG PET/CTIn: Journal of Nuclear Medicine (JNM), Jg. 55, 2014, Nr. 3, S. 373 – 378DOI (Open Access)
-
A new anastomotic leakage model in circular double stapled colorectal anastomosis after low anterior rectum resection in pigsIn: Journal of Investigative Surgery, Jg. 26, 2013, Nr. 6, S. 364 – 372
-
Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar CholangiocarcinomaIn: Annals of Surgical Oncology, Jg. 20, 2013, Nr. 1, S. 277 – 284
-
Feasibility of preemptive biomarker profiling for personalised early clinical drug development at a Comprehensive Cancer CenterIn: European Journal of Cancer (EJC), Jg. 49, 2013, Nr. 15, S. 3076 – 3082
-
Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancerIn: PLoS ONE, Jg. 8, 2013, Nr. 11, S. e80084DOI (Open Access)
-
Mammalian target of rapamycin pathway activity in alveolar soft part sarcomaIn: Human Pathology, Jg. 44, 2013, Nr. 10, S. 2266 – 2274
-
Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockadeIn: Oncogene, Jg. 32, 2013, Nr. 23, S. 2873 – 2881
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Breast Cancer Research and Treatment, Jg. 142, 2013, Nr. 1, S. 81 – 88
-
Talgdrüsenheterotopie im Ösophagus : Fallbericht in Zusammenschau mit der LiteraturIn: Der Pathologe, Jg. 34, 2013, Nr. 2, S. 162 – 164
-
High insulin-like growth factor mRNA-binding protein 3 (IMP3) protein expression is associated with poor survival in muscle-invasive bladder cancerIn: BJU International (BJUI), Jg. 110, 2012, Nr. 6B, S. E308 – E317DOI (Open Access)
-
Serum endostatin levels correlate with enhanced extracellular matrix degradation and poor patients' prognosis in bladder cancerIn: International Journal of Cancer, Jg. 130, 2012, Nr. 12, S. 2922 – 2929
-
Targeting the anti-apoptotic protein BCL-XL to overcome RAS mediated resistance to anti-EGFR antibody therapy in colorectal cancerIn: Onkologie, Jg. 35, 2012, Nr. Suppl. 6, S. 253
-
The Action of Small GTPases Rab11 and Rab25 in Vesicle Trafficking During Cell MigrationIn: Cellular Physiology and Biochemistry, Jg. 29, 2012, Nr. 5-6, S. 647 – 656
-
Tissue MMP-7 expression predicts survival in bladder cancer patients treated with cisplatin-based chemotherapyIn: The Journal of Urology, Jg. 187, 2012, Nr. Suppl. 4, S. E575 – E575
-
Tumor vessel stabilization and remodeling by anti-angiogenic therapy with bevacizumabIn: Histochemistry and Cell Biology, Jg. 137, 2012, Nr. 3, S. 391 – 401
-
Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomyIn: International Journal of Cancer, Jg. 128, 2011, Nr. 6, S. 1486 – 1492
-
Expression of GLUT1 is associated with increasing grade of malignancy in non-invasive and invasive urothelial carcinomas of the bladderIn: Oncology Letters, Jg. 2, 2011, Nr. 6, S. 1149 – 1153DOI (Open Access)
-
Fulminant septic shock due to Clostridium perfringens skin and soft tissue infection eight years after liver transplantationIn: Annals of Transplantation, Jg. 16, 2011, Nr. 3, S. 143 – 146
-
Klatskin-mimicking lesions : Still a diagnostical and therapeutical dilemma?In: Hepato-gastroenterology Journal, Jg. 58, 2011, Nr. 106, S. 265 – 269
-
Lack of Association of the Genotype in the GNAS Fok I Polymorphism and Prostate CancerIn: Urologia Internationalis, Jg. 87, 2011, Nr. 1, S. 80 – 86
-
Rektale Magenschleimhautheterotopie : Ein Fallbericht in Zusammenschau mit der LiteraturIn: Der Pathologe, Jg. 32, 2011, Nr. 6, S. 521 – 524
-
TTF-1- (Klon 8G7G3/1) positives Kolonkarzinom : Diagnostische ImplikationenIn: Der Pathologe, Jg. 32, 2011, Nr. 4, S. 349 – 351
-
The Toll-like receptor (TLR) 4 variant D299G promotes inflammation-associated colon cancer progression in the intestinal epitheliumIn: Inflammatory Bowel Diseases, Jg. 17, 2011, Nr. Suppl. 2, S. S84
-
Toll-like Receptor 4 Variant D299G Induces Features of Neoplastic Progression in Caco-2 Intestinal Cells and Is Associated With Advanced Human Colon CancerIn: Gastroenterology, Jg. 141, 2011, Nr. 6, S. 2154 – 2165
-
Tumor markers as a diagnostic key for hilar cholangiocarcinomaIn: European Journal of Medical Research, Jg. 15, 2010, Nr. 8, S. 357 – 361DOI (Open Access)
-
Combined analysis of hypoxia-inducible factor 1 alpha and metallothionein indicates an aggressive subtype of colorectal carcinomaIn: International Journal of Colorectal Disease, Jg. 24, 2009, Nr. 11, S. 1287 – 1296
-
Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infectionIn: Journal of Hepatology, Jg. 48, 2008, Nr. 1, S. 83 – 90
-
AKT and ERK1/2 signaling in intrahepatic cholangiocarcinomaIn: World Journal of Gastroenterology, Jg. 13, 2007, Nr. 48, S. 6470
-
Elevated expression of cyclooxygenase-2 is a negative prognostic factor for overall survival in intrahepatic cholangiocarcinomaIn: Virchows Archiv, Jg. 450, 2007, Nr. 2, S. 135 – 141DOI (Open Access)
-
GNAS1 T393C polymorphism is associated with clinical course in patients with intrahepatic cholangiocarcinomaIn: Neoplasia: An International Journal for Oncology Research, Jg. 9, 2007, Nr. 2, S. 159 – 165DOI (Open Access)
-
Apoptotische Gastritis nach Immuncheckpointblockade : Ein typisches histopathologisches MusterIn: Journal der Deutschen Dermatologischen Gesellschaft (JDDG). Hoboken: Wiley-Blackwell - STM, Jg. 18, 2020, Nr. Suppl. 2: Special Issue: Abstractband anlässlich des 30. Deutschen Hautkrebskongresses (ADO‐Jahrestagung) 09.–12. September 2020, S. P12DOI (Open Access)
-
How Caveolin-1 regulates the ceramide-mediated radiation-response of endothelial cells in the context of tumor-stroma-interactions
26. Jahrestagung der Deutschen Gesellschaft für Radioonkologie (DEGRO) ; 24. - 28. Juni 2020, Wiesbaden, Germany,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 196, 2020, Nr. 1 Supplement: Abstracts DEGRO 2020, S. S214DOI (Open Access) -
Development of predictors for PD-1/PD-L1-directed therapy of non-small cell lung cancer (NSCLC) by gene expression profiling of small diagnostic biopsies (DBX)In: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 36, 2018, Nr. 15 Suppl., S. e15121DOI (Open Access)
-
How stromal Caveolin-1 alters the radiation response of prostate tumors
24. Jahrestagung der Deutschen Gesellschaft für Radioonkologie, 21. Juni 2018 - 24. Juni 2018, Leipzig,In: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 194, 2018, Nr. 1 Supplement, Abstracts DEGRO 2018, S. S171 – S172DOI (Open Access) -
PD-L1 Expression in Urothelial Carcinoma with Divergent Differentiation, Concordance among Three Antibodies
Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,In: Modern Pathology. Amsterdam: Elsevier, Jg. 31, 2018, Nr. Suppl. 2, S. 377 – 378DOI (Open Access) -
Potentially Targetable Molecular Alterations in 70 Cases of Urachal Cancer
Geared to Learn ; USCAP 107th Annual Meeting ; March 17–23, 2018, Vancouver,In: Modern Pathology. Amsterdam: Elsevier, Jg. 31, 2018, Nr. Suppl. 2, S. 378DOI (Open Access) -
Signaling network activation in colorectal cancer : p70S6K phosphorylation as a prognostic marker
33. Deutscher Krebskongress - Perspektiven verändern Krebs - Krebs verändert Perspektiven. Diagnose - Therapie - (Über-)Leben ; 21.-24. Februar 2018, Berlin,In: Oncology Research and Treatment. Basel: Karger, Jg. 41, 2018, Nr. Suppl. 1, S. 55DOI (Open Access) -
Nuclear Magnetic Resonance Analysis of fat in pretransplant liver biopsies - a novel approach to asses liver steatosisIn: Transplant International. Lausanne: Frontiers Media, Jg. 29, 2016, Nr. Suppl. 3, S. 8 – 9
-
Stromal Caveolin-1 regulates radiosensitivity of epithelial prostate tumorsIn: Strahlentherapie und Onkologie: Journal of Radiation Oncology, Biology, Physics. Heidelberg: Springer, Jg. 191, 2015, Nr. Suppl. 1, S. S27
-
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastatic breast cancer patientsIn: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1: 31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie Berlin, 19.-22. Februar 2014: Abstracts, S. 19DOI (Open Access)
-
TRY : A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutationIn: Journal of Clinical Oncology (JCO). Alexandria: American Society of Clinical Oncology (ASCO), Jg. 32, 2014, Nr. 15, Suppl., S. 8109
-
WTZ-Tumorprofil-A preemptive biomarker profiling program in relation to personalized clinical drug development at a large German Comprehensive Cancer Center : Two years experience
31. Deutscher Krebskongress iKON - intelligente Konzepte in der Onkologie, 19.-22. Februar 2014, Berlin, Germany,In: Oncology Research and Treatment. Basel: Karger, Jg. 37, 2014, Nr. Suppl. 1, S. 2 – 3 -
Molecular dissection of effector mechanisms of RAS-induced resistance to monoclonal anti-EGFR antibodies
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Onkologie. Basel: Karger, Jg. 36, 2013, Nr. Suppl. 7, S. 116 – 117 -
Preemptive tumor profiling for biomarker-stratified early clinical drug development in metastastic breast cancer patients
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie, 18.-22. Oktober 2013, Wien, Österreich,In: Oncology Research and Treatment. Basel: Karger, Jg. 36, 2013, Nr. Suppl. 7, S. 157 -
465 Vascular Remodeling of Tumor Blood Vessels as a Result of Anti-angiogenic Therapy : the Role of Vascular Wall-resident Mesenchymal Stem Cells Within These ProcessesIn: European Journal of Cancer (EJC). Amsterdam: Elsevier, Jg. 48, 2012, Nr. Supplement 5, S. S112
-
Detektion, Evaluation und Validierung prädiktiver und diagnostischer Biomarker in der modernen Pathologie am Beispiel onkologischer Erkrankungen und der TransplatationspathologieDuisburg ; Essen, 2016
-
Biologische Relevanz des GS-Alpha-T93C- und des G-Beta-C825T-Polymorphismus bei hepatisch metastiertem kolorektalem KarzinomDuisburg, Essen, 2009
-
Inzidenz und Überleben von Patienten mit Urothelkarzinom in Nordrhein-Westfalen (NRW) : Analyse des Landeskrebsregister (LKR) von den Jahren 2008-2019
Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 7.–10. Oktober 2022, Wien, Austria,In: Oncology Research and Treatment. Basel: Karger, Jg. 45, 2022, Nr. Supplement 2, S. 318DOI (Open Access)